nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—Fentanyl—Diphenhydramine—atopic dermatitis	0.368	1	CrCrCtD
Sufentanil—CYP3A4—Pimecrolimus—atopic dermatitis	0.0971	0.258	CbGbCtD
Sufentanil—CYP3A4—Tacrolimus—atopic dermatitis	0.0577	0.153	CbGbCtD
Sufentanil—CYP3A4—Loratadine—atopic dermatitis	0.0423	0.112	CbGbCtD
Sufentanil—CYP3A4—Methylprednisolone—atopic dermatitis	0.0387	0.103	CbGbCtD
Sufentanil—CYP3A4—Triamcinolone—atopic dermatitis	0.0293	0.0778	CbGbCtD
Sufentanil—CYP3A4—Betamethasone—atopic dermatitis	0.0251	0.0668	CbGbCtD
Sufentanil—CYP3A4—Prednisolone—atopic dermatitis	0.0248	0.0659	CbGbCtD
Sufentanil—CYP3A4—Hydrocortisone—atopic dermatitis	0.0235	0.0624	CbGbCtD
Sufentanil—CYP3A4—Prednisone—atopic dermatitis	0.0234	0.0622	CbGbCtD
Sufentanil—CYP3A4—Dexamethasone—atopic dermatitis	0.0146	0.0388	CbGbCtD
Sufentanil—Euphoric mood—Dimenhydrinate—atopic dermatitis	0.00331	0.0198	CcSEcCtD
Sufentanil—Euphoric mood—Diphenhydramine—atopic dermatitis	0.00331	0.0198	CcSEcCtD
Sufentanil—Pulmonary function test decreased—Tacrolimus—atopic dermatitis	0.00269	0.0161	CcSEcCtD
Sufentanil—Respiratory depression—Tacrolimus—atopic dermatitis	0.00269	0.0161	CcSEcCtD
Sufentanil—Urinary retention—Dimenhydrinate—atopic dermatitis	0.00266	0.0159	CcSEcCtD
Sufentanil—Urinary retention—Diphenhydramine—atopic dermatitis	0.00266	0.0159	CcSEcCtD
Sufentanil—Erythema—Desonide—atopic dermatitis	0.0023	0.0138	CcSEcCtD
Sufentanil—Urinary incontinence—Tacrolimus—atopic dermatitis	0.00196	0.0117	CcSEcCtD
Sufentanil—Erythema—Fluocinonide—atopic dermatitis	0.00187	0.0112	CcSEcCtD
Sufentanil—Chills—Dimenhydrinate—atopic dermatitis	0.00173	0.0104	CcSEcCtD
Sufentanil—Chills—Diphenhydramine—atopic dermatitis	0.00173	0.0104	CcSEcCtD
Sufentanil—Erythema—Pimecrolimus—atopic dermatitis	0.00163	0.00974	CcSEcCtD
Sufentanil—Bronchospasm—Mometasone—atopic dermatitis	0.00157	0.00939	CcSEcCtD
Sufentanil—Urinary retention—Tacrolimus—atopic dermatitis	0.0014	0.00836	CcSEcCtD
Sufentanil—Cardiac arrest—Tacrolimus—atopic dermatitis	0.0014	0.00836	CcSEcCtD
Sufentanil—Confusional state—Diphenhydramine—atopic dermatitis	0.00139	0.00829	CcSEcCtD
Sufentanil—Confusional state—Dimenhydrinate—atopic dermatitis	0.00139	0.00829	CcSEcCtD
Sufentanil—Tachycardia—Diphenhydramine—atopic dermatitis	0.00134	0.00802	CcSEcCtD
Sufentanil—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00134	0.00802	CcSEcCtD
Sufentanil—Pruritus—Desonide—atopic dermatitis	0.00133	0.00796	CcSEcCtD
Sufentanil—Arrhythmia—Loratadine—atopic dermatitis	0.00133	0.00796	CcSEcCtD
Sufentanil—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.00133	0.00795	CcSEcCtD
Sufentanil—Hypotension—Dimenhydrinate—atopic dermatitis	0.00128	0.00768	CcSEcCtD
Sufentanil—Hypotension—Diphenhydramine—atopic dermatitis	0.00128	0.00768	CcSEcCtD
Sufentanil—Somnolence—Diphenhydramine—atopic dermatitis	0.00122	0.00731	CcSEcCtD
Sufentanil—Somnolence—Dimenhydrinate—atopic dermatitis	0.00122	0.00731	CcSEcCtD
Sufentanil—Rash—Desonide—atopic dermatitis	0.00119	0.00709	CcSEcCtD
Sufentanil—Dermatitis—Desonide—atopic dermatitis	0.00118	0.00709	CcSEcCtD
Sufentanil—Headache—Desonide—atopic dermatitis	0.00118	0.00705	CcSEcCtD
Sufentanil—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.00116	0.00697	CcSEcCtD
Sufentanil—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00113	0.00677	CcSEcCtD
Sufentanil—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00113	0.00677	CcSEcCtD
Sufentanil—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00112	0.00671	CcSEcCtD
Sufentanil—Hypertension—Loratadine—atopic dermatitis	0.00112	0.00669	CcSEcCtD
Sufentanil—Euphoric mood—Prednisolone—atopic dermatitis	0.00111	0.00665	CcSEcCtD
Sufentanil—Euphoric mood—Hydrocortisone—atopic dermatitis	0.00109	0.00649	CcSEcCtD
Sufentanil—Pruritus—Fluocinonide—atopic dermatitis	0.00108	0.00645	CcSEcCtD
Sufentanil—Anaphylactic shock—Loratadine—atopic dermatitis	0.00106	0.00633	CcSEcCtD
Sufentanil—Body temperature increased—Pimecrolimus—atopic dermatitis	0.00105	0.00628	CcSEcCtD
Sufentanil—Bradycardia—Tacrolimus—atopic dermatitis	0.00104	0.00619	CcSEcCtD
Sufentanil—Tachycardia—Loratadine—atopic dermatitis	0.00103	0.00618	CcSEcCtD
Sufentanil—Euphoric mood—Triamcinolone—atopic dermatitis	0.00102	0.00611	CcSEcCtD
Sufentanil—Euphoric mood—Methylprednisolone—atopic dermatitis	0.00102	0.0061	CcSEcCtD
Sufentanil—Dizziness—Fluocinonide—atopic dermatitis	0.00101	0.00603	CcSEcCtD
Sufentanil—Urinary tract disorder—Tacrolimus—atopic dermatitis	0.001	0.00601	CcSEcCtD
Sufentanil—Urethral disorder—Tacrolimus—atopic dermatitis	0.000997	0.00596	CcSEcCtD
Sufentanil—Hypotension—Loratadine—atopic dermatitis	0.000989	0.00591	CcSEcCtD
Sufentanil—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000979	0.00585	CcSEcCtD
Sufentanil—Rash—Fluocinonide—atopic dermatitis	0.000961	0.00575	CcSEcCtD
Sufentanil—Dermatitis—Fluocinonide—atopic dermatitis	0.00096	0.00574	CcSEcCtD
Sufentanil—Headache—Fluocinonide—atopic dermatitis	0.000954	0.00571	CcSEcCtD
Sufentanil—Somnolence—Loratadine—atopic dermatitis	0.000941	0.00563	CcSEcCtD
Sufentanil—Pruritus—Pimecrolimus—atopic dermatitis	0.00094	0.00562	CcSEcCtD
Sufentanil—Euphoric mood—Dexamethasone—atopic dermatitis	0.000927	0.00555	CcSEcCtD
Sufentanil—Euphoric mood—Betamethasone—atopic dermatitis	0.000927	0.00555	CcSEcCtD
Sufentanil—Chills—Tacrolimus—atopic dermatitis	0.000913	0.00546	CcSEcCtD
Sufentanil—Arrhythmia—Tacrolimus—atopic dermatitis	0.000909	0.00544	CcSEcCtD
Sufentanil—Dizziness—Diphenhydramine—atopic dermatitis	0.000908	0.00543	CcSEcCtD
Sufentanil—Dizziness—Dimenhydrinate—atopic dermatitis	0.000908	0.00543	CcSEcCtD
Sufentanil—Anaphylactic shock—Mometasone—atopic dermatitis	0.000908	0.00543	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisolone—atopic dermatitis	0.000893	0.00534	CcSEcCtD
Sufentanil—Erythema—Tacrolimus—atopic dermatitis	0.000885	0.0053	CcSEcCtD
Sufentanil—Vomiting—Diphenhydramine—atopic dermatitis	0.000873	0.00522	CcSEcCtD
Sufentanil—Vomiting—Dimenhydrinate—atopic dermatitis	0.000873	0.00522	CcSEcCtD
Sufentanil—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.000872	0.00522	CcSEcCtD
Sufentanil—Feeling abnormal—Loratadine—atopic dermatitis	0.000872	0.00522	CcSEcCtD
Sufentanil—Rash—Diphenhydramine—atopic dermatitis	0.000866	0.00518	CcSEcCtD
Sufentanil—Rash—Dimenhydrinate—atopic dermatitis	0.000866	0.00518	CcSEcCtD
Sufentanil—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000865	0.00518	CcSEcCtD
Sufentanil—Dermatitis—Diphenhydramine—atopic dermatitis	0.000865	0.00518	CcSEcCtD
Sufentanil—Headache—Diphenhydramine—atopic dermatitis	0.000861	0.00515	CcSEcCtD
Sufentanil—Headache—Dimenhydrinate—atopic dermatitis	0.000861	0.00515	CcSEcCtD
Sufentanil—Vomiting—Pimecrolimus—atopic dermatitis	0.000844	0.00505	CcSEcCtD
Sufentanil—Rash—Pimecrolimus—atopic dermatitis	0.000837	0.00501	CcSEcCtD
Sufentanil—Dermatitis—Pimecrolimus—atopic dermatitis	0.000837	0.00501	CcSEcCtD
Sufentanil—Body temperature increased—Loratadine—atopic dermatitis	0.000836	0.005	CcSEcCtD
Sufentanil—Headache—Pimecrolimus—atopic dermatitis	0.000832	0.00498	CcSEcCtD
Sufentanil—Cardiac arrest—Triamcinolone—atopic dermatitis	0.000821	0.00491	CcSEcCtD
Sufentanil—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.000819	0.0049	CcSEcCtD
Sufentanil—Nausea—Dimenhydrinate—atopic dermatitis	0.000816	0.00488	CcSEcCtD
Sufentanil—Nausea—Diphenhydramine—atopic dermatitis	0.000816	0.00488	CcSEcCtD
Sufentanil—Euphoric mood—Prednisone—atopic dermatitis	0.000808	0.00483	CcSEcCtD
Sufentanil—Nausea—Pimecrolimus—atopic dermatitis	0.000789	0.00472	CcSEcCtD
Sufentanil—Hypertension—Tacrolimus—atopic dermatitis	0.000764	0.00457	CcSEcCtD
Sufentanil—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000752	0.0045	CcSEcCtD
Sufentanil—Cardiac arrest—Betamethasone—atopic dermatitis	0.000745	0.00446	CcSEcCtD
Sufentanil—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000745	0.00446	CcSEcCtD
Sufentanil—Bronchospasm—Methylprednisolone—atopic dermatitis	0.000733	0.00438	CcSEcCtD
Sufentanil—Confusional state—Tacrolimus—atopic dermatitis	0.000729	0.00436	CcSEcCtD
Sufentanil—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000723	0.00432	CcSEcCtD
Sufentanil—Body temperature increased—Mometasone—atopic dermatitis	0.000718	0.00429	CcSEcCtD
Sufentanil—Tachycardia—Tacrolimus—atopic dermatitis	0.000705	0.00422	CcSEcCtD
Sufentanil—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.000701	0.00419	CcSEcCtD
Sufentanil—Dizziness—Loratadine—atopic dermatitis	0.0007	0.00419	CcSEcCtD
Sufentanil—Hypotension—Tacrolimus—atopic dermatitis	0.000675	0.00404	CcSEcCtD
Sufentanil—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000673	0.00402	CcSEcCtD
Sufentanil—Vomiting—Loratadine—atopic dermatitis	0.000673	0.00402	CcSEcCtD
Sufentanil—Rash—Loratadine—atopic dermatitis	0.000667	0.00399	CcSEcCtD
Sufentanil—Dermatitis—Loratadine—atopic dermatitis	0.000666	0.00399	CcSEcCtD
Sufentanil—Headache—Loratadine—atopic dermatitis	0.000663	0.00396	CcSEcCtD
Sufentanil—Bradycardia—Prednisolone—atopic dermatitis	0.000661	0.00396	CcSEcCtD
Sufentanil—Cardiac arrest—Prednisone—atopic dermatitis	0.000649	0.00388	CcSEcCtD
Sufentanil—Bradycardia—Hydrocortisone—atopic dermatitis	0.000646	0.00386	CcSEcCtD
Sufentanil—Somnolence—Tacrolimus—atopic dermatitis	0.000642	0.00384	CcSEcCtD
Sufentanil—Pruritus—Mometasone—atopic dermatitis	0.000642	0.00384	CcSEcCtD
Sufentanil—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000629	0.00376	CcSEcCtD
Sufentanil—Nausea—Loratadine—atopic dermatitis	0.000628	0.00376	CcSEcCtD
Sufentanil—Bradycardia—Triamcinolone—atopic dermatitis	0.000608	0.00364	CcSEcCtD
Sufentanil—Bradycardia—Methylprednisolone—atopic dermatitis	0.000607	0.00363	CcSEcCtD
Sufentanil—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000605	0.00362	CcSEcCtD
Sufentanil—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000599	0.00359	CcSEcCtD
Sufentanil—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000599	0.00358	CcSEcCtD
Sufentanil—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000596	0.00356	CcSEcCtD
Sufentanil—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000595	0.00356	CcSEcCtD
Sufentanil—Arrhythmia—Prednisolone—atopic dermatitis	0.00058	0.00347	CcSEcCtD
Sufentanil—Vomiting—Mometasone—atopic dermatitis	0.000577	0.00345	CcSEcCtD
Sufentanil—Rash—Mometasone—atopic dermatitis	0.000572	0.00342	CcSEcCtD
Sufentanil—Dermatitis—Mometasone—atopic dermatitis	0.000572	0.00342	CcSEcCtD
Sufentanil—Body temperature increased—Tacrolimus—atopic dermatitis	0.000571	0.00342	CcSEcCtD
Sufentanil—Headache—Mometasone—atopic dermatitis	0.000569	0.0034	CcSEcCtD
Sufentanil—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000567	0.00339	CcSEcCtD
Sufentanil—Erythema—Prednisolone—atopic dermatitis	0.000566	0.00338	CcSEcCtD
Sufentanil—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000565	0.00338	CcSEcCtD
Sufentanil—Erythema—Hydrocortisone—atopic dermatitis	0.000552	0.0033	CcSEcCtD
Sufentanil—Bradycardia—Betamethasone—atopic dermatitis	0.000552	0.0033	CcSEcCtD
Sufentanil—Bradycardia—Dexamethasone—atopic dermatitis	0.000552	0.0033	CcSEcCtD
Sufentanil—Nausea—Mometasone—atopic dermatitis	0.000539	0.00323	CcSEcCtD
Sufentanil—Arrhythmia—Triamcinolone—atopic dermatitis	0.000534	0.00319	CcSEcCtD
Sufentanil—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000533	0.00319	CcSEcCtD
Sufentanil—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000532	0.00318	CcSEcCtD
Sufentanil—Erythema—Triamcinolone—atopic dermatitis	0.00052	0.00311	CcSEcCtD
Sufentanil—Erythema—Methylprednisolone—atopic dermatitis	0.000519	0.0031	CcSEcCtD
Sufentanil—Pruritus—Tacrolimus—atopic dermatitis	0.000511	0.00306	CcSEcCtD
Sufentanil—Hypertension—Prednisolone—atopic dermatitis	0.000488	0.00292	CcSEcCtD
Sufentanil—Arrhythmia—Dexamethasone—atopic dermatitis	0.000484	0.0029	CcSEcCtD
Sufentanil—Arrhythmia—Betamethasone—atopic dermatitis	0.000484	0.0029	CcSEcCtD
Sufentanil—Bradycardia—Prednisone—atopic dermatitis	0.000481	0.00287	CcSEcCtD
Sufentanil—Dizziness—Tacrolimus—atopic dermatitis	0.000478	0.00286	CcSEcCtD
Sufentanil—Hypertension—Hydrocortisone—atopic dermatitis	0.000477	0.00285	CcSEcCtD
Sufentanil—Erythema—Betamethasone—atopic dermatitis	0.000472	0.00282	CcSEcCtD
Sufentanil—Erythema—Dexamethasone—atopic dermatitis	0.000472	0.00282	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000462	0.00276	CcSEcCtD
Sufentanil—Vomiting—Tacrolimus—atopic dermatitis	0.000459	0.00275	CcSEcCtD
Sufentanil—Rash—Tacrolimus—atopic dermatitis	0.000456	0.00273	CcSEcCtD
Sufentanil—Dermatitis—Tacrolimus—atopic dermatitis	0.000455	0.00272	CcSEcCtD
Sufentanil—Headache—Tacrolimus—atopic dermatitis	0.000453	0.00271	CcSEcCtD
Sufentanil—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000451	0.0027	CcSEcCtD
Sufentanil—Tachycardia—Prednisolone—atopic dermatitis	0.00045	0.00269	CcSEcCtD
Sufentanil—Hypertension—Triamcinolone—atopic dermatitis	0.000449	0.00269	CcSEcCtD
Sufentanil—Hypertension—Methylprednisolone—atopic dermatitis	0.000448	0.00268	CcSEcCtD
Sufentanil—Tachycardia—Hydrocortisone—atopic dermatitis	0.00044	0.00263	CcSEcCtD
Sufentanil—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.000439	0.00498	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000439	0.00497	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00043	0.00487	CbGpPWpGaD
Sufentanil—Nausea—Tacrolimus—atopic dermatitis	0.000429	0.00257	CcSEcCtD
Sufentanil—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.000429	0.00486	CbGpPWpGaD
Sufentanil—Confusional state—Methylprednisolone—atopic dermatitis	0.000427	0.00255	CcSEcCtD
Sufentanil—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000424	0.00254	CcSEcCtD
Sufentanil—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000423	0.00253	CcSEcCtD
Sufentanil—Arrhythmia—Prednisone—atopic dermatitis	0.000422	0.00252	CcSEcCtD
Sufentanil—Hypotension—Hydrocortisone—atopic dermatitis	0.000421	0.00252	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000421	0.00477	CbGpPWpGaD
Sufentanil—Tachycardia—Triamcinolone—atopic dermatitis	0.000414	0.00248	CcSEcCtD
Sufentanil—Tachycardia—Methylprednisolone—atopic dermatitis	0.000413	0.00247	CcSEcCtD
Sufentanil—Erythema—Prednisone—atopic dermatitis	0.000411	0.00246	CcSEcCtD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000409	0.00463	CbGpPWpGaD
Sufentanil—Hypertension—Dexamethasone—atopic dermatitis	0.000407	0.00244	CcSEcCtD
Sufentanil—Hypertension—Betamethasone—atopic dermatitis	0.000407	0.00244	CcSEcCtD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000407	0.00462	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.000406	0.0046	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000399	0.00453	CbGpPWpGaD
Sufentanil—Hypotension—Methylprednisolone—atopic dermatitis	0.000396	0.00237	CcSEcCtD
Sufentanil—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000393	0.00446	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000393	0.00446	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000386	0.00437	CbGpPWpGaD
Sufentanil—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000385	0.0023	CcSEcCtD
Sufentanil—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000385	0.0023	CcSEcCtD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000385	0.00436	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000382	0.00433	CbGpPWpGaD
Sufentanil—Feeling abnormal—Prednisolone—atopic dermatitis	0.00038	0.00228	CcSEcCtD
Sufentanil—Tachycardia—Dexamethasone—atopic dermatitis	0.000376	0.00225	CcSEcCtD
Sufentanil—Tachycardia—Betamethasone—atopic dermatitis	0.000376	0.00225	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.000373	0.00423	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000373	0.00422	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000372	0.00422	CbGpPWpGaD
Sufentanil—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000371	0.00222	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000369	0.00418	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000363	0.00411	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000362	0.0041	CbGpPWpGaD
Sufentanil—Hypotension—Betamethasone—atopic dermatitis	0.00036	0.00215	CcSEcCtD
Sufentanil—Hypotension—Dexamethasone—atopic dermatitis	0.00036	0.00215	CcSEcCtD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000357	0.00405	CbGpPWpGaD
Sufentanil—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000356	0.00213	CcSEcCtD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000356	0.00403	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000356	0.00403	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000355	0.00402	CbGpPWpGaD
Sufentanil—Hypertension—Prednisone—atopic dermatitis	0.000355	0.00212	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00035	0.00397	CbGpPWpGaD
Sufentanil—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00035	0.00209	CcSEcCtD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000349	0.00396	CbGpPWpGaD
Sufentanil—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000349	0.00209	CcSEcCtD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000345	0.00391	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.000343	0.00389	CbGpPWpGaD
Sufentanil—Hypersensitivity—Prednisolone—atopic dermatitis	0.00034	0.00203	CcSEcCtD
Sufentanil—Body temperature increased—Triamcinolone—atopic dermatitis	0.000336	0.00201	CcSEcCtD
Sufentanil—Anaphylactic shock—Prednisone—atopic dermatitis	0.000335	0.00201	CcSEcCtD
Sufentanil—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000332	0.00199	CcSEcCtD
Sufentanil—Tachycardia—Prednisone—atopic dermatitis	0.000327	0.00196	CcSEcCtD
Sufentanil—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.000327	0.00371	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000326	0.0037	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000325	0.00369	CbGpPWpGaD
Sufentanil—Pruritus—Hydrocortisone—atopic dermatitis	0.000319	0.00191	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000317	0.0036	CbGpPWpGaD
Sufentanil—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000317	0.0019	CcSEcCtD
Sufentanil—Feeling abnormal—Betamethasone—atopic dermatitis	0.000317	0.0019	CcSEcCtD
Sufentanil—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000313	0.00187	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000312	0.00354	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000312	0.00354	CbGpPWpGaD
Sufentanil—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000312	0.00187	CcSEcCtD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000312	0.00353	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000311	0.00353	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000306	0.00347	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000305	0.00346	CbGpPWpGaD
Sufentanil—Dizziness—Prednisolone—atopic dermatitis	0.000305	0.00183	CcSEcCtD
Sufentanil—Body temperature increased—Dexamethasone—atopic dermatitis	0.000304	0.00182	CcSEcCtD
Sufentanil—Body temperature increased—Betamethasone—atopic dermatitis	0.000304	0.00182	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000304	0.00345	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000302	0.00342	CbGpPWpGaD
Sufentanil—Pruritus—Triamcinolone—atopic dermatitis	0.0003	0.0018	CcSEcCtD
Sufentanil—Pruritus—Methylprednisolone—atopic dermatitis	0.0003	0.00179	CcSEcCtD
Sufentanil—Dizziness—Hydrocortisone—atopic dermatitis	0.000298	0.00178	CcSEcCtD
Sufentanil—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.000297	0.00337	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000296	0.00335	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000292	0.0033	CbGpPWpGaD
Sufentanil—Rash—Prednisolone—atopic dermatitis	0.000291	0.00174	CcSEcCtD
Sufentanil—Dermatitis—Prednisolone—atopic dermatitis	0.000291	0.00174	CcSEcCtD
Sufentanil—Headache—Prednisolone—atopic dermatitis	0.000289	0.00173	CcSEcCtD
Sufentanil—Vomiting—Hydrocortisone—atopic dermatitis	0.000287	0.00171	CcSEcCtD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000286	0.00324	CbGpPWpGaD
Sufentanil—Rash—Hydrocortisone—atopic dermatitis	0.000284	0.0017	CcSEcCtD
Sufentanil—Dermatitis—Hydrocortisone—atopic dermatitis	0.000284	0.0017	CcSEcCtD
Sufentanil—Headache—Hydrocortisone—atopic dermatitis	0.000282	0.00169	CcSEcCtD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000282	0.0032	CbGpPWpGaD
Sufentanil—Dizziness—Triamcinolone—atopic dermatitis	0.000281	0.00168	CcSEcCtD
Sufentanil—Dizziness—Methylprednisolone—atopic dermatitis	0.00028	0.00168	CcSEcCtD
Sufentanil—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000276	0.00313	CbGpPWpGaD
Sufentanil—Feeling abnormal—Prednisone—atopic dermatitis	0.000276	0.00165	CcSEcCtD
Sufentanil—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000276	0.00313	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000275	0.00312	CbGpPWpGaD
Sufentanil—Nausea—Prednisolone—atopic dermatitis	0.000274	0.00164	CcSEcCtD
Sufentanil—Pruritus—Dexamethasone—atopic dermatitis	0.000272	0.00163	CcSEcCtD
Sufentanil—Pruritus—Betamethasone—atopic dermatitis	0.000272	0.00163	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000271	0.00307	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000271	0.00307	CbGpPWpGaD
Sufentanil—Vomiting—Triamcinolone—atopic dermatitis	0.00027	0.00161	CcSEcCtD
Sufentanil—Vomiting—Methylprednisolone—atopic dermatitis	0.000269	0.00161	CcSEcCtD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000268	0.00304	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000268	0.00304	CbGpPWpGaD
Sufentanil—Nausea—Hydrocortisone—atopic dermatitis	0.000268	0.0016	CcSEcCtD
Sufentanil—Rash—Triamcinolone—atopic dermatitis	0.000268	0.0016	CcSEcCtD
Sufentanil—Dermatitis—Triamcinolone—atopic dermatitis	0.000267	0.0016	CcSEcCtD
Sufentanil—Rash—Methylprednisolone—atopic dermatitis	0.000267	0.0016	CcSEcCtD
Sufentanil—Dermatitis—Methylprednisolone—atopic dermatitis	0.000267	0.0016	CcSEcCtD
Sufentanil—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000267	0.00302	CbGpPWpGaD
Sufentanil—Headache—Triamcinolone—atopic dermatitis	0.000266	0.00159	CcSEcCtD
Sufentanil—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000266	0.00301	CbGpPWpGaD
Sufentanil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000265	0.00301	CbGpPWpGaD
Sufentanil—Headache—Methylprednisolone—atopic dermatitis	0.000265	0.00159	CcSEcCtD
Sufentanil—Body temperature increased—Prednisone—atopic dermatitis	0.000265	0.00159	CcSEcCtD
Sufentanil—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.000265	0.003	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000264	0.00299	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000264	0.00299	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000263	0.00298	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.00026	0.00295	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000259	0.00293	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000256	0.0029	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000255	0.00289	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000255	0.00289	CbGpPWpGaD
Sufentanil—Dizziness—Betamethasone—atopic dermatitis	0.000255	0.00152	CcSEcCtD
Sufentanil—Dizziness—Dexamethasone—atopic dermatitis	0.000255	0.00152	CcSEcCtD
Sufentanil—Nausea—Triamcinolone—atopic dermatitis	0.000252	0.00151	CcSEcCtD
Sufentanil—Nausea—Methylprednisolone—atopic dermatitis	0.000252	0.0015	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000247	0.0028	CbGpPWpGaD
Sufentanil—Hypersensitivity—Prednisone—atopic dermatitis	0.000247	0.00148	CcSEcCtD
Sufentanil—Vomiting—Betamethasone—atopic dermatitis	0.000245	0.00146	CcSEcCtD
Sufentanil—Vomiting—Dexamethasone—atopic dermatitis	0.000245	0.00146	CcSEcCtD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000243	0.00275	CbGpPWpGaD
Sufentanil—Rash—Dexamethasone—atopic dermatitis	0.000243	0.00145	CcSEcCtD
Sufentanil—Rash—Betamethasone—atopic dermatitis	0.000243	0.00145	CcSEcCtD
Sufentanil—Dermatitis—Betamethasone—atopic dermatitis	0.000243	0.00145	CcSEcCtD
Sufentanil—Dermatitis—Dexamethasone—atopic dermatitis	0.000243	0.00145	CcSEcCtD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000242	0.00274	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000241	0.00273	CbGpPWpGaD
Sufentanil—Headache—Dexamethasone—atopic dermatitis	0.000241	0.00144	CcSEcCtD
Sufentanil—Headache—Betamethasone—atopic dermatitis	0.000241	0.00144	CcSEcCtD
Sufentanil—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.000238	0.00269	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.000238	0.00269	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.000237	0.00269	CbGpPWpGaD
Sufentanil—Pruritus—Prednisone—atopic dermatitis	0.000237	0.00142	CcSEcCtD
Sufentanil—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.000234	0.00265	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000233	0.00264	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.000232	0.00263	CbGpPWpGaD
Sufentanil—Nausea—Betamethasone—atopic dermatitis	0.000229	0.00137	CcSEcCtD
Sufentanil—Nausea—Dexamethasone—atopic dermatitis	0.000229	0.00137	CcSEcCtD
Sufentanil—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000226	0.00257	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.000225	0.00255	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000224	0.00254	CbGpPWpGaD
Sufentanil—Dizziness—Prednisone—atopic dermatitis	0.000222	0.00133	CcSEcCtD
Sufentanil—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.00022	0.00249	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000219	0.00248	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000216	0.00245	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000215	0.00243	CbGpPWpGaD
Sufentanil—Vomiting—Prednisone—atopic dermatitis	0.000213	0.00128	CcSEcCtD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000213	0.00241	CbGpPWpGaD
Sufentanil—Rash—Prednisone—atopic dermatitis	0.000211	0.00127	CcSEcCtD
Sufentanil—Dermatitis—Prednisone—atopic dermatitis	0.000211	0.00126	CcSEcCtD
Sufentanil—Headache—Prednisone—atopic dermatitis	0.00021	0.00126	CcSEcCtD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000209	0.00237	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.000208	0.00236	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000204	0.00231	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.000201	0.00228	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.000201	0.00228	CbGpPWpGaD
Sufentanil—Nausea—Prednisone—atopic dermatitis	0.000199	0.00119	CcSEcCtD
Sufentanil—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000197	0.00223	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000197	0.00223	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.000196	0.00222	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000192	0.00217	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.000191	0.00217	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000189	0.00214	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.000189	0.00214	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000188	0.00213	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.000185	0.0021	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00018	0.00204	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.000176	0.00199	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.000175	0.00199	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000173	0.00196	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000172	0.00195	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.000168	0.0019	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.000167	0.00189	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000166	0.00189	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.000166	0.00188	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.000162	0.00184	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000162	0.00184	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000159	0.0018	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.000156	0.00177	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.000156	0.00177	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.000154	0.00174	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.000153	0.00174	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000153	0.00174	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000151	0.00171	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00015	0.0017	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.000149	0.00169	CbGpPWpGaD
Sufentanil—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000146	0.00166	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.000146	0.00166	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000146	0.00165	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.000142	0.00161	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.000142	0.00161	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.00014	0.00159	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.00014	0.00159	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.000139	0.00158	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.000139	0.00158	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.000137	0.00155	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.000137	0.00155	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.000137	0.00155	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000136	0.00155	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000134	0.00152	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.000134	0.00152	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000132	0.0015	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000132	0.00149	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.00013	0.00147	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.000129	0.00147	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000127	0.00144	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.000125	0.00142	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.000125	0.00141	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.000123	0.0014	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000123	0.0014	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.000123	0.00139	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.000122	0.00138	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.000122	0.00138	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000121	0.00138	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.00012	0.00136	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000116	0.00131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.000116	0.00131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.000116	0.00131	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000114	0.00129	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.000114	0.00129	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.000113	0.00128	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.000113	0.00128	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.000113	0.00128	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000111	0.00126	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.00011	0.00125	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.00011	0.00124	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000106	0.00121	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000106	0.0012	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000106	0.0012	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000105	0.00118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000104	0.00118	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000103	0.00117	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000103	0.00117	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000101	0.00115	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000101	0.00114	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	9.92e-05	0.00112	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	9.92e-05	0.00112	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.8e-05	0.00111	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	9.67e-05	0.0011	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	9.58e-05	0.00109	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	9.49e-05	0.00108	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	9.41e-05	0.00107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	9.32e-05	0.00106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	9.27e-05	0.00105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	9.22e-05	0.00104	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	9.16e-05	0.00104	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	9e-05	0.00102	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	8.83e-05	0.001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	8.55e-05	0.000969	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	8.38e-05	0.00095	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	8.38e-05	0.00095	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	8.32e-05	0.000943	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	8.26e-05	0.000936	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NPS—atopic dermatitis	8.22e-05	0.000931	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	8.22e-05	0.000931	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	8.17e-05	0.000926	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	8.08e-05	0.000916	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	8.06e-05	0.000913	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	7.88e-05	0.000893	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	7.74e-05	0.000878	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL5—atopic dermatitis	7.64e-05	0.000866	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	7.5e-05	0.00085	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	7.46e-05	0.000846	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NPS—atopic dermatitis	7.2e-05	0.000816	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	7.2e-05	0.000816	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	7.07e-05	0.000801	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	7.03e-05	0.000797	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	6.98e-05	0.000791	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	6.83e-05	0.000774	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL5—atopic dermatitis	6.7e-05	0.000759	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	6.51e-05	0.000738	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	6.34e-05	0.000718	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	6.09e-05	0.00069	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NPS—atopic dermatitis	6.09e-05	0.00069	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	5.97e-05	0.000677	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	5.71e-05	0.000647	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.69e-05	0.000645	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL5—atopic dermatitis	5.66e-05	0.000641	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	5.61e-05	0.000635	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	5.44e-05	0.000616	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NGF—atopic dermatitis	5.19e-05	0.000588	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	5.17e-05	0.000586	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	5.05e-05	0.000572	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.99e-05	0.000566	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	4.94e-05	0.00056	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	4.92e-05	0.000557	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	4.83e-05	0.000547	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	4.77e-05	0.000541	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NGF—atopic dermatitis	4.55e-05	0.000516	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	4.53e-05	0.000514	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	4.43e-05	0.000502	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	4.33e-05	0.000491	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	4.28e-05	0.000485	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.22e-05	0.000478	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	4.15e-05	0.000471	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	4.03e-05	0.000457	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NGF—atopic dermatitis	3.85e-05	0.000436	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	3.83e-05	0.000434	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.82e-05	0.000433	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	3.75e-05	0.000425	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	3.74e-05	0.000424	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.66e-05	0.000415	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	3.66e-05	0.000415	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	3.17e-05	0.00036	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	3.05e-05	0.000346	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL2—atopic dermatitis	2.92e-05	0.000331	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	2.9e-05	0.000329	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.69e-05	0.000304	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	2.68e-05	0.000303	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL2—atopic dermatitis	2.56e-05	0.00029	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	2.55e-05	0.000289	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	2.36e-05	0.000267	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.26e-05	0.000256	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL2—atopic dermatitis	2.16e-05	0.000245	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	2.15e-05	0.000244	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.99e-05	0.000226	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.72e-05	0.000194	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—atopic dermatitis	1.5e-05	0.00017	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.27e-05	0.000144	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.24e-05	0.000141	CbGpPWpGaD
